|
|
|
Insider
Information: |
Isis Pharmaceuticals Inc |
Relationship: |
10% Owner |
City: |
Carlsbad |
State: |
CA |
|
|
Insider
Summary: |
|
|
|
Companies Owned : |
2 |
|
Direct
Shares |
82,267,854 |
|
Indirect Shares
|
98,322,397 |
|
|
Direct
Value |
$1,409,930,242 |
|
|
Indirect Value
|
$1,783,568,282 |
|
|
Total
Shares |
180,590,251 |
|
|
Total
Value |
$3,193,498,523 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
Total
Filings :
|
0
|
0
|
Stock
price went up :
|
0
|
0
|
Stock
price went down : |
0
|
0
|
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
Percentage
Gain/Loss : |
0.0%
|
0.0%
|
|
|
|
|
|
|
Holdings
:
Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold |
|
Regulus Therapeutics Inc. |
RGLS |
10% Owner |
2015-07-17 |
5,173,172 |
2012-10-10 |
0 |
Premium* |
|
Akcea Therapeutics Inc |
AKCA |
10% Owner |
2019-12-17 |
77,094,682 |
2020-10-10 |
98,322,397 |
Premium* |
|
|
|
|
|
|
|
|
|
|
Records found :
20 |
Free Registration Required For Full Results. Limit: 25
|
|
Download |
Page 1 of 1
|
Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
AKCA |
Akcea Therapeutics Inc |
10% Owner |
|
2020-10-10 |
4 |
B |
$18.15 |
$385,464,527 |
I/I |
21,237,715 |
98,322,397 |
1.5 |
- |
|
AKCA |
Akcea Therapeutics Inc |
10% Owner |
|
2019-12-17 |
4 |
A |
$0.00 |
$0 |
D/D |
6,873,344 |
77,094,682 |
0 |
- |
|
AKCA |
Akcea Therapeutics Inc |
10% Owner |
|
2019-03-29 |
4 |
A |
$0.00 |
$0 |
D/D |
2,837,373 |
70,221,338 |
0 |
- |
|
AKCA |
Akcea Therapeutics Inc |
10% Owner |
|
2018-10-17 |
4 |
A |
$0.00 |
$0 |
D/D |
1,671,849 |
67,383,965 |
0 |
- |
|
AKCA |
Akcea Therapeutics Inc |
10% Owner |
|
2018-08-03 |
4 |
A |
$0.00 |
$0 |
D/D |
1,597,571 |
65,712,116 |
0 |
- |
|
AKCA |
Akcea Therapeutics Inc |
10% Owner |
|
2018-04-17 |
4 |
A |
$0.00 |
$0 |
D/D |
8,000,000 |
53,447,879 |
0 |
- |
|
AKCA |
Akcea Therapeutics Inc |
10% Owner |
|
2018-04-17 |
4 |
B |
$18.75 |
$199,999,988 |
D/D |
10,666,666 |
64,114,545 |
2.45 |
- |
|
AKCA |
Akcea Therapeutics Inc |
10% Owner |
|
2017-07-19 |
4 |
B |
$8.00 |
$25,000,000 |
D/D |
3,125,000 |
45,447,879 |
2.45 |
- |
|
AKCA |
Akcea Therapeutics Inc |
10% Owner |
|
2017-07-19 |
4 |
A |
$0.00 |
$0 |
D/D |
13,438,339 |
42,322,879 |
0 |
- |
|
AKCA |
Akcea Therapeutics Inc |
10% Owner |
|
2017-07-19 |
4 |
A |
$0.00 |
$0 |
D/D |
28,884,540 |
28,884,540 |
0 |
- |
|
RGLS |
Regulus Therapeutics Inc. |
10% Owner |
|
2015-07-17 |
4 |
S |
$10.21 |
$1,133,754 |
D/D |
(111,000) |
5,173,172 |
0 |
- |
|
RGLS |
Regulus Therapeutics Inc. |
10% Owner |
|
2015-07-16 |
4 |
S |
$10.79 |
$1,801,362 |
D/D |
(167,000) |
5,284,172 |
0 |
- |
|
RGLS |
Regulus Therapeutics Inc. |
10% Owner |
|
2015-07-15 |
4 |
S |
$10.76 |
$700,961 |
D/D |
(65,133) |
5,451,172 |
0 |
- |
|
RGLS |
Regulus Therapeutics Inc. |
10% Owner |
|
2015-06-30 |
4 |
S |
$10.79 |
$143,010 |
D/D |
(13,248) |
5,516,305 |
0 |
- |
|
RGLS |
Regulus Therapeutics Inc. |
10% Owner |
|
2015-06-23 |
4 |
GA |
$0.00 |
$0 |
D/D |
13,248 |
5,529,553 |
0 |
- |
|
RGLS |
Regulus Therapeutics Inc. |
Director |
|
2014-10-24 |
4/A |
AS |
$14.63 |
$28,109 |
D/D |
(1,850) |
6,795,716 |
0 |
- |
|
RGLS |
Regulus Therapeutics Inc. |
Director |
|
2014-10-23 |
4/A |
AS |
$13.94 |
$24,202 |
D/D |
(1,700) |
6,797,566 |
0 |
- |
|
RGLS |
Regulus Therapeutics Inc. |
Director |
|
2014-10-22 |
4/A |
AS |
$12.18 |
$1,533,135 |
D/D |
(109,534) |
6,799,266 |
0 |
- |
|
RGLS |
Regulus Therapeutics Inc. |
10% Owner |
|
2012-10-10 |
4 |
B |
$4.00 |
$3,000,000 |
D/D |
750,000 |
7,049,500 |
2.45 |
- |
|
RGLS |
Regulus Therapeutics Inc. |
10% Owner |
|
2012-10-10 |
4 |
A |
$0.00 |
$0 |
D/D |
6,299,500 |
6,299,500 |
0 |
- |
|
20 Records found
|
1
|
Page 1 of 1 |
|
Free Registration Required For Full Results. Limit: 25
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|